Jane Street’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-88,133
Closed -$2.7M 12264
2026
Q1
$2.94M Buy
+88,133
New +$2.96M ﹤0.01% 4388
2025
Q4
Sell
-158,660
Closed -$5.06M 11706
2025
Q3
$4.32M Buy
158,660
+144,498
+1,020% +$3.49M ﹤0.01% 3645
2025
Q2
$298K Sell
14,162
-35,516
-71% -$681K ﹤0.01% 7875
2025
Q1
$814K Sell
49,678
-5,256
-10% -$112K ﹤0.01% 5963
2024
Q4
$1.41M Sell
54,934
-24,603
-31% -$697K ﹤0.01% 4758
2024
Q3
$2.52M Sell
79,537
-49,476
-38% -$1.88M ﹤0.01% 4019
2024
Q2
$4.53M Buy
129,013
+99,235
+333% +$3.93M ﹤0.01% 3114
2024
Q1
$1.31M Sell
29,778
-11,259
-27% -$484K ﹤0.01% 4907
2023
Q4
$1.46M Buy
41,037
+23,119
+129% +$690K ﹤0.01% 4875
2023
Q3
$483K Sell
17,918
-43,267
-71% -$1.1M ﹤0.01% 6353
2023
Q2
$1.44M Sell
61,185
-1,997
-3% -$41.1K ﹤0.01% 4649
2023
Q1
$867K Buy
63,182
+49,496
+362% +$825K ﹤0.01% 5282
2022
Q4
$249K Buy
+13,686
New +$230K ﹤0.01% 7327
2022
Q1
Sell
-15,361
Closed -$363K 10628
2021
Q4
$363K Buy
+15,361
New +$357K ﹤0.01% 7822
2020
Q3
Sell
-12,554
Closed -$179K 7491
2020
Q2
$179K Buy
+12,554
New +$98.9K ﹤0.01% 6438

Other funds holding IDYA

Jane Street's IDYA Position: Q2 2026 in Review

Jane Street sold out of IDEAYA Biosciences (IDYA) in Q2 2026, closing a stake of 88,133 shares — an estimated $2.7M sold.

Jane Street first reported a position in IDYA in Q2 2020 and held it in 15 quarters. The position peaked at $4.53M in Q2 2024. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Jane Street reported no remaining IDEAYA Biosciences position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 88,133 IDEAYA Biosciences shares in Q2 2026, an estimated $2.7M.
  • Jane Street first reported a position in IDEAYA Biosciences in Q2 2020 and held it in 15 quarters.
  • Jane Street's IDEAYA Biosciences position peaked at $4.53M in Q2 2024.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.